A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT03900598 · COMPLETED

Trial details

NCT number: NCT03900598
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma, Non-Hodgkin

Start date: 2019-04-03
Primary completion: 2025-05-22
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.